Jupiter Research Capital (Asia) Ltd’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
Other funds holding CTMX
KCM
Jupiter Research Capital (Asia) Ltd's CTMX Position: Q3 2026 in Review
Jupiter Research Capital (Asia) Ltd opened a new position in CytomX Therapeutics (CTMX) in Q3 2026: 16,029 shares worth $43.6K. The stake represents ﹤0.01% of the portfolio and ranks #674 among its holdings.
185 funds tracked by Wall St. Rank hold CTMX as of Q3 2026.
- Jupiter Research Capital (Asia) Ltd held 16,029 shares of CytomX Therapeutics worth $43.6K as of Q3 2026.
- CytomX Therapeutics was a new Jupiter Research Capital (Asia) Ltd position in Q3 2026.
- CytomX Therapeutics made up ﹤0.01% of Jupiter Research Capital (Asia) Ltd's portfolio in Q3 2026, its #674 holding.
- 185 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q3 2026.
Based on Jupiter Research Capital (Asia) Ltd's 13F filing for Q3 2026, filed 16 Nov 2026.